FDA clears Vasomedical's Holter monitors

Brian Dunham | | Health Imaging | Screening
Vasomedical has received FDA market clearance for two new monitors: the Biox Model 1303 3-channel ECG Holter Monitor and Model 1304 12-channel ECG Holter Monitor.

The approval of the two new monitors completes a line of ambulatory monitoring products for long-term recording and analysis of ECG and blood pressure data, according to the company. Vasomedical added that its Biox monitors work with CB Series Analysis Software.

Vasomedical will showcase its Biox products at the upcoming Florida International Medical Expo in Miami Beach, Fla., from Aug. 11-12 and the European Society of Cardiology Congress in Paris, Aug. 27-30.

Brian Dunham

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.